Introduction

The National Center for Health Statistics (NCHS) reported an 18.4% increase in US maternal mortality (ie, death during pregnancy or within 42 days of pregnancy) between 2019 and 2020. The relative increase was 44.4% among Hispanic, 25.7% among non-Hispanic Black, and 6.1% among non-Hispanic White women.1 Given a 16.8% increase in overall US mortality in 2020, largely attributed to the COVID-19 pandemic,2 we examined the pandemic’s role in 2020 maternal death rates.

Methods

This study was exempt from review under the US Department of Health and Human Services regulation for secondary data analysis; consent was not required for vital records. We followed the STROBE reporting guideline.

We used deidentified NCHS mortality and natality files from 2018 to 2020. We limited analyses to maternal deaths (International Statistical Classification of Diseases and Related Health Problems, Tenth Revision [ICD-10] codes A34, O00-O95, and O98-O99) based on underlying cause of death in accordance with NCHS guidelines.3 None of these ICD-10 codes exclusively identify COVID-19 (ICD-10 U07.1) as the cause even when COVID-19 was a factor in maternal death (eMethods in the Supplement). Therefore, COVID-19 was ascertained as a secondary cause from the multiple causes-of-death section, consistent with other reports on excess mortality from COVID-19.4

Deaths were stratified by month, and year of death was stratified into before (2018, 2019, and January-March [quarter 1] 2020) or during (April-December [quarters 2-4] 2020) the pandemic. Maternal mortality rates and percentages with a secondary COVID-19 code were compared by timing, race and ethnicity, and underlying cause (which were all included in NCHS data). Differences were assessed using a z test of proportions. Two-sided P = .05 indicated statistical significance.

Results

A total of 1588 maternal deaths (18.8 per 100 000 live births) occurred before the pandemic vs 684 deaths (25.1 per 100 000 live births) during the pandemic, a relative increase of 33.3% (Table). Late maternal mortality increased by 41%. Absolute and relative changes were highest for Hispanic (8.9 per 100 000 live births and 74.2%, respectively) and non-Hispanic Black (16.8 per 100 000 live births and 40.2%) vs non-Hispanic White (2.9 per 100 000 live births and 17.2%) women (Figure). A secondary code for COVID-19 was listed in 14.9% (102 of 684) of maternal deaths in quarters 2 to 4, with 0% in quarter 1 of 2020. This percentage was highest among Hispanic women (32.1%), followed by non-Hispanic Black (12.9%) and non-Hispanic White (7.3%) women.

Table.  Cause-Specific Maternal Mortality Rates Before vs During the COVID-19 Pandemic and Percentage of Secondary COVID-19 Cause Codes
Obstetric cause-of-death category (ICD-10 O-codes)cPrepandemicaDuring pandemicbRelative change in rates, %eAbsolute change in rates per 100 000 live birthsP valuefCOVID-19 (ICD-10 U07.1) listed as a multiple cause in quarters 2-4 2020, No. (%)g
No. (rate per 100 000 live births)d95% CINo. (rate per 100 000 live births)d95% CI
Total coded to maternal causes during pregnancy or within 42 d after pregnancy (A34, O00-O95, O98-O99)1588 (18.8)17.9-19.8684 (25.1)23.2-27.033.36.3<.001102 (14.9)
Obstetric death of unspecified cause (O95)57 (0.7)0.5-0.912 (NR)NR–34.9–0.2.170
Total direct obstetric causes (A34, O00-O92)1109 (13.2)12.4-13.9458 (16.8)15.3-18.427.73.7<.00160 (13.1)
Pregnancy with abortive outcome (O00-O07)61 (0.7)0.5-0.921 (0.8)0.4-1.16.50.1.801 (4.8)
Hypertensive disorders (O10-O16)158 (1.9)1.6-2.271 (2.6)2.0-3.239.00.7.027 (9.9)
Obstetric hemorrhage (O20, O43.2, O44-O46, O67, O71.0, O71.1, O71.3, O71.4, O71.7, O72)92 (1.1)0.9-1.338 (1.4)1.0-1.827.80.3.210
Pregnancy-related infection (O23, O41.1, O75.3, O85, O86, O91)28 (0.3)0.2-0.512 (NR)NR 32.60.1.410
Venous thrombosis in pregnancy (O22.0, O22.2, O22.3, O22.5, O22.9)26 (0.3)0.2-0.48 (NR)NR –4.8–0.0.901 (12.5)
Diabetes in pregnancy (O24)30 (0.4)0.2-0.519 (0.7)0.4-1.095.90.3.024 (21.1)
Liver disorders in pregnancy (O26.6)66 (0.8)0.6-1.025 (0.9)0.6-1.317.20.1.501 (4.0)
Other specified pregnancy-related conditions (O26.8)397 (4.7)4.3-5.2190 (7.0)6.0-8.048.02.3<.00143 (22.6)
Other complications of obstetric surgery and procedures (O75.4)40 (0.5)0.3-0.67 (NR)NR –45.9–0.2.131 (14.3)
Obstetric embolism (O88)86 (1.0)0.8-1.227 (1.0)0.6-1.3–2.9–0.0.770
Cardiomyopathy in the puerperium (O90.3)61 (0.7)0.5-0.922 (0.8)0.5-1.111.60.1.660
Total indirect causes (O98-O99)422 (5.0)4.5-5.5214 (7.9)6.8-8.956.92.9<.00142 (19.6)
Other viral diseases (O98.5)2 (NR)NR 16 (0.6)0.3-0.92374.70.6<.00116 (100.0)
Other maternal infectious and parasitic diseases (O98.8)21 (0.3)0.1-0.413 (NR)NR 91.50.2.065 (38.5)
Mental disorders and diseases of the nervous system (O99.3)25 (0.3)0.2-0.410 (NR)NR 23.70.1.571 (10.0)
Diseases of the circulatory system (O99.4)133 (1.6)1.3-1.974 (2.7)2.1-3.372.11.1.0011 (1.4)
Diseases of the respiratory system (O99.5)27 (0.3)0.2-0.419 (0.7)0.4-1.1117.70.4.0111 (57.9)
Other specified diseases and conditions (O99.8)183 (2.2)1.9-2.573 (2.7)2.1-3.323.40.5.136 (8.2)
Total nonspecific causes (O26.8, O95, O99.8)637 (7.6)7.0-8.2275 (10.1)8.9-11.333.52.5.00149 (17.8)
Total coded to late maternal causes after 42 d or within 1 y (O96)691 (8.2)7.6-8.8315 (11.6)10.3-12.841.03.4<.00134 (10.8)
Figure.  US Maternal Mortality Rates (95% CI) Before and During the COVID-19 Pandemic by Race and Ethnicity

All rates met standards of reliability (numerator >16 deaths), which corresponded to SEs that were below 25% of the rate under the assumption of a Poisson distribution. P values were based on z test of proportions comparing the period during the pandemic (April-December 2020) with the period before the pandemic (2018, 2019, and January-March 2020).

For underlying cause-of-death codes (Table), the largest relative increase was among indirect causes (56.9%), specifically other viral diseases (2374.7%), diseases of the respiratory system (117.7%), and diseases of the circulatory system (72.1%). Relative increases in direct causes (27.7%) were mostly associated with diabetes in pregnancy (95.9%), hypertensive disorders (39.0%), and other specified pregnancy-related conditions (48.0%). COVID-19 was commonly listed as a secondary condition with other viral diseases (16 of 16 deaths [100%]) and diseases of the respiratory system (11 of 19 deaths [57.9%]) (Table). Almost half of those with a secondary code for COVID-19 (49 of 102) had a nonspecific code (ICD-10 O26.8 or O99.8) as the underlying cause.

Discussion

In the US, maternal deaths increased substantially (33.3%) after March 2020, corresponding to COVID-19 onset, a figure higher than the 22% overall excess death estimate associated with the pandemic.4 Increases were highest for Hispanic and non-Hispanic Black women. Change in maternal deaths during the pandemic may involve conditions directly related to COVID-19 (respiratory or viral infection) or conditions exacerbated by COVID-19 or other health care disruptions (diabetes or cardiovascular disease)5 but could not be discerned from the data.

Study limitations include the large percentage of COVID-19 cases with a nonspecific underlying cause (reflecting a maternal death coding problem6) and partitioning of data that resulted in small numbers for some categories (rates were suppressed for <16 deaths). Future studies of maternal death should examine the contribution of the pandemic to racial and ethnic disparities and should identify specific causes of maternal deaths overall and associated with COVID-19.

Back to top
Article Information

Accepted for Publication: March 26, 2022.

Published: June 28, 2022. doi:10.1001/jamanetworkopen.2022.19133

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Thoma ME et al. JAMA Network Open.

Corresponding Author: Marie E. Thoma, PhD, Department of Family Science, School of Public Health, University of Maryland, 4200 Valley Dr, Family Science Ste 1142, College Park, MD 20742 ([email protected]).

Author Contributions: Dr Thoma had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: All authors.

Acquisition, analysis, or interpretation of data: Thoma.

Drafting of the manuscript: Thoma.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Thoma.

Conflict of Interest Disclosures: None reported.

References
1.
Hoyert  DL. Maternal mortality rates in the United States, 2020. Health E-Stat. February 23, 2022. Accessed May 5, 2022. https://www.cdc.gov/nchs/data/hestat/maternal-mortality/2020/E-stat-Maternal-Mortality-Rates-2022.pdf
2.
Murphy  SL, Kochanek  KD, Xu  J, Arias  E.  Mortality in the United States, 2020.   NCHS Data Brief. 2021;(427):1-8.PubMedGoogle Scholar
3.
Hoyert  DL, Miniño  AM.  Maternal mortality in the United States: changes in coding, publication, and data release, 2018.   Natl Vital Stat Rep. 2020;69(2):1-18.PubMedGoogle Scholar
4.
Woolf  SH, Chapman  DA, Sabo  RT, Zimmerman  EB.  Excess deaths from COVID-19 and other causes in the US, March 1, 2020, to January 2, 2021.   JAMA. 2021;325(17):1786. doi:10.1001/jama.2021.5199 PubMedGoogle ScholarCrossref
5.
Pérez-López  FR, Savirón-Cornudella  R, Chedraui  P,  et al.  Obstetric and perinatal outcomes of pregnancies with COVID 19: a systematic review and meta-analysis.   J Matern Fetal Neonatal Med. Published online March 13, 2022. doi:10.1080/14767058.2022.2051008 PubMedGoogle ScholarCrossref
6.
MacDorman  MF, Thoma  M, Declercq  E.  Improving US maternal mortality reporting by analyzing literal text on death certificates, United States, 2016-2017.   PLoS One. 2020;15(10):e0240701. doi:10.1371/journal.pone.0240701 PubMedGoogle ScholarCrossref